Gene Query: UHRF1BP1L

Dataset Description Geneva Score
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 25.06
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 20.44
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 20.44
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 18.62
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 18.62
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 18.33
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 16.75
Transcriptomic profiling of human peripheral blood-derived mast cells 16.75
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 16.11
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 14.99
An RNA-centric dissection of host complexes controlling flavivirus infection 13.83
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 13.83
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 12.72
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 12.72
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 12.63
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 12.49
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 12.15
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 11.65
SUV420H2 knockdown in PANC-1 11.61
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 11.5
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 11.29
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 10.66
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 10.44
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 10.44
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 10.31
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 10.25
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 10.01
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 10.0
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 10.0
R430: A potent inbibitor of DNA and RNA viruses 9.78
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 9.66
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 9.66
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 9.58
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 9.39
WRN knockout effects upon gene expression in SW48 and OVK18 9.27
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 9.23
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 9.18
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 8.88
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 8.85
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 8.85
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 8.79
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 8.68
Tumor exosome integrins determine organotropic metastasis 8.66
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 8.65
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 8.6
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 8.56
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 8.32
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 8.28
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 8.25
Differentially expressed genes post knock down of lincDUSP26 8.14
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 8.09
Proliferation-correlated expression 8.01
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 7.81
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 7.81
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 7.81
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 7.8
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 7.78
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 7.72
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 7.68
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 7.62
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 7.62
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 7.59
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 7.38
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 7.38
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 7.38
Effect of Hotair overexpression in human breast cancer cell lines 7.24
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 7.16
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 7.13
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 7.11
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 7.11
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 7.04
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 7.02
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 6.98
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 6.96
Gene expression analysis upon mtDNA depletion 6.92
Gene expression analysis upon mtDNA depletion [RNA-seq] 6.92
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 6.88
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 6.85
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 6.83
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 6.64
RNAseq Analysis in glioblastoma cells treated with Mepazine 6.59
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 6.59
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 6.58
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 6.57
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 6.55
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 6.55
Tracking of dCas9-methyltransferase footprints 6.54
Gene expression in PANC1 cells treated with Rakicidin 6.52
Paxillin regulates genomic networks in prostate cancer [C4-2] 6.52
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 6.47
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 6.46
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 6.44
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 6.42
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 6.42
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 6.37
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 6.29
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 6.29
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 6.26
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 6.21
Dysregulated immune system networks in war veterans with PTSD 6.19
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 6.14
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 6.13
Impact of dieldrin on transcription in Jurkat T cells 6.11
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 6.07
Peptidomimetic blockade of MYB in acute myeloid leukemia 6.07
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 6.06
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 6.05
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 6.05
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 6.04
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 6.03
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 6.03
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 5.95
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 5.95
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 5.94
ETV7 and interferon response 5.93
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 5.93
Selective suppression of endothelial cytokine production by progesterone receptor 5.9
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 5.9
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 5.86
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 5.84
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 5.84
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 5.8
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 5.7
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 5.69
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 5.69
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 5.68
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 5.64
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 5.6
Overexpression and knockdown experiment for circCSNK1G3 5.56
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 5.53
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 5.53
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 5.53
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 5.52
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 5.46
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 5.46
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 5.43
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 5.42
Characterization of human ILC2 subsets 5.4
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 5.39
ARID1A regulates condensin II distribution and chromosomal partition 5.39
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 5.37
RNA expression analysis upon JMJD1C depletion 5.3
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 5.3
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 5.28
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 5.27
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 5.25
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 5.23
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 5.2
RNA-seq analysis of AML cells in response to ASLAN003 5.17
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 5.16
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 5.16
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 5.16
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 5.11
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 5.1
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 5.07
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 5.07
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 5.07
U2AF1 mutations alter splice site recognition in hematological malignancies 5.06
RNA-seq of resting and activated CD4+ T cells +-JQ1 5.06
Functional role of SLIT2 and ROBO1 in trophoblasts 5.05
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 5.03
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 5.0
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 5.0
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.98
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 4.96
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 4.95
Human Treg IFNg/IL-10 subpopulations 4.94
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 4.9
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 4.9
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 4.87
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 4.82
Regulation of protein translation during mitosis 4.82
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 4.81
IMP3 regulated gene expression in breast cancer cells 4.8
LncRNA-GAS5 negative regulation of YAP-target genes expression 4.76
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 4.75
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 4.74
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 4.63
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 4.62
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 4.62
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 4.6
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 4.58
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 4.56
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 4.56
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 4.55
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 4.53
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 4.53
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 4.52
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 4.51
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 4.5
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 4.49
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 4.49
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 4.48
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.46
Gene expression profile in breast cancer cells 4.46
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 4.46
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 4.45
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 4.45
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 4.45
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.43
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 4.39
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 4.37
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 4.37
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 4.35
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.34
MYCL and EP400 are required for Max and MCPyV mediated gene activation 4.31
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 4.31
RIG-I and MDA5 fRIP during KSHV lytic reactivation 4.27
The contribution of Alu exons to the human proteome 4.26
Expression and functions of long noncoding RNAs during human T helper cell differentiation 4.24
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 4.22
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 4.21
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 4.21
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 4.16
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 4.14
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 4.14
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 4.14
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 4.12
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 4.1
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 4.09
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 4.07
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 4.05
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 4.05
TT-Seq captures the human transient transcriptome 4.04
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 4.03
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 4.03
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 4.02
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 3.99
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 3.97
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 3.94
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 3.91
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 3.91
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 3.9
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 3.88
Global Mapping of Human RNA-RNA Interactions 3.88
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 3.86
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 3.85
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 3.82
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 3.82
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 3.8
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 3.8
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 3.77
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 3.77
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 3.77
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 3.77
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 3.74
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 3.73
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 3.73
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 3.68
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 3.65
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 3.63
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 3.63
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 3.61
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 3.61
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 3.56
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 3.53
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 3.5
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 3.46
The Genomic Landscape of Atypical Fibroxanthoma 3.44
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 3.43
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 3.42
Modeling Human Cancer-induced Cachexia (Human) 3.41
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 3.4
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 3.36
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 3.31
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 3.31
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 3.3
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 3.29
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 3.29
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 3.28
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 3.27
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 3.26
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 3.24
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 3.24
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 3.24
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 3.2
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 3.2
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 3.19
Transcription control by the ENL YEATS domain in acute leukemia 3.19
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 3.19
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 3.18
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 3.15
RNA-seq of MDA-MB-231 cells with TET1 knockout 3.15
RNAseq in Alzheimer's Disease patients 3.09
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 3.08
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 3.07
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 3.07
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 3.05
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.01
Effect of PRDM11 depletion in U2932 cells 3.01
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.99
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.99
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 2.99
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 2.97
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.97
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 2.95
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 2.88
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 2.88
RNA-seq of cells with TET1 knockout 2.87
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 2.84
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 2.81
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.8
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.8
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 2.77
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 2.73
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 2.73
Transcriptional profile in human S. haematobium infection 2.73
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.71
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 2.71
NAPRT activation of macrophages 2.7
Transcriptome of activated human and mouse MAIT cells 2.69
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 2.68
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 2.68
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 2.68
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.67
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.66
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 2.66
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.66
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.66
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 2.65
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 2.6
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 2.57
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 2.57
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 2.55
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 2.54
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 2.52
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.52
Hepatitis C virus functionally sequesters miR-122 2.5
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 2.5
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 2.49
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 2.48
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 2.48
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 2.44
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 2.43
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.43
The role of CFTR in islet function 2.41
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 2.41
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 2.4
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.4
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 2.39
Human Treg NaCl stimulation 2.35
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 2.35
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 2.3
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.27
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 2.25
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 2.24
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 2.23
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.21
Gene expression analysis of human hepatocellular cancers 2.19
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 2.19
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 2.16
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 2.16
Transcription elongation regulates genome 3D structure 2.15
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.14
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 2.12
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 2.1
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 2.09
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 2.09
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.03
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 2.03
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 2.01
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 1.98
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 1.97
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 1.96
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 1.95
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 1.95
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 1.9
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 1.85
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.79
RNA-Seq in neutrophils from Antiphospholipid Syndrome 1.79
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 1.78
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 1.77
LINE-2 transposable elements are a source of functional human microRNAs and target sites 1.76
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 1.76
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 1.75
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 1.74
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 1.73
Aneuploidy-induced cellular stresses limit autophagic degradation. 1.73
BASP1 modifies the Tamoxifen response 1.73
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 1.71
FBXW7 modulates stress response by post-translational modification of HSF1 1.71
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 1.71
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 1.71
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 1.69
Specific molecular signatures underlie response to decitabine in CMML 1.69
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.68
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.64
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.64
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 1.62
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 1.53
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 1.48
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 1.46
JAK dependent survival of ALK- ALCL 1.45
Aging-associated patterns in the expression of human endogenous retroviruses 1.45
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.42
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 1.4
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 1.39
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 1.38
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.36
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.36
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 1.36
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 1.36
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.35
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.34
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 1.34
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 1.32
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.29
Transcriptome analysis of peripheral blood monocytes 1.28
Human Treg IL-12 stimulation 1.26
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.25
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.25
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 1.24
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 1.22
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 1.22
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.19
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 1.19
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 1.17
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 1.17
Role of COP1 on MAP kinase transcriptional output in melanoma 1.14
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.14
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.1
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.08
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 1.06
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 1.06
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.05
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.05
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.02
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.97
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 0.96
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.88
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.87
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.86
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 0.85
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.82
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.79
p63 controls the enhancer landscape during keratinocyte differentiation 0.76
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.73
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.72
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.72
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.7
RNAseq of Breast cancer PDX samples 0.68
RNA-seq analysis of control and Myc-induced U2OS cells 0.66
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.66
The role of the Calcium-Sensing receptor in colorectal cancer 0.66
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 0.66
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 0.65
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.63
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.62
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.62
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 0.6
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 0.6
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 0.6
High-resolution comparative analysis of great ape genomes 0.59
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.59
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 0.58
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.53
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 0.52
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.51
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.51
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.49
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 0.49
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 0.46
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.43
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.41
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.37
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.37
RNA-seq of primary patient AML samples 0.37
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.36
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.34
Direct Isolation and Characterization of Human Nephron Progenitors. 0.33
Discovering human diabetes-risk gene function with genetics and physiological assays 0.32
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 0.3
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.3
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.3
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.29
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 0.27
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 0.27
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.23
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.22
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 0.19
FOXP1 orchestration of ASD-relevant signaling pathways. 0.19
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.18
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.17
Modulation of nonsense-mediated decay by rapamycin 0.16
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.16
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.13
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.12
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.11
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.09
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.09
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.09
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 0.08
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.07
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.05
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.04
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.02
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.02
A code of mono-phosphorylation modulates the function of RB. 0.01
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation